The abstract of the report on the phase 3 trial of Regorafenib in GIST is now available online at PubMed. The original full report was published in the British journal 'Lancet' on January 26, 2013. You can read the abstract by clicking the link below:
"Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial."
Support for people living with GastroIntestinal Stromal Tumor (GIST) in the Chicago Area
No comments:
Post a Comment
Comments are moderated. So there may be a delay before a comment appears on the site.